Patents by Inventor Shuang Ren

Shuang Ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11872221
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator, optionally in combination with a dipeptidyl peptidase-4 inhibitor.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: January 16, 2024
    Assignee: HUA Medicine (Shanghai) Ltd.
    Inventors: Li Chen, Shuang Ren, Jiayi Zhang
  • Patent number: 11857536
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a glucokinase-mediated disorder, disease, or condition in a renally impaired subject with a glucokinase activator (GKA), for example, dorzagliatin. Also provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a diabetes in a renally impaired subject with a GKA. Additionally, provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a chronic kidney disease with a GKA.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: January 2, 2024
    Assignee: HUA Medicine (Shanghai) Ltd.
    Inventors: Li Chen, Shuang Ren, Chengfeng Jiao, Yaohui Wang
  • Patent number: 11813274
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator and a sodium-glucose cotransporter-2 inhibitor.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: November 14, 2023
    Assignee: HUA Medicine (Shanghai) Ltd.
    Inventors: Li Chen, Shuang Ren, Jiayi Zhang
  • Publication number: 20230270723
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a glucokinase-mediated disorder, disease, or condition in a hepatically impaired subject with a glucokinase activator (GKA), for example, dorzagliatin. Also provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a diabetes in a hepatically impaired subject with a GKA. Additionally, provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a chronic liver disease with a GKA.
    Type: Application
    Filed: June 3, 2021
    Publication date: August 31, 2023
    Inventors: Li CHEN, Shuang REN, Chengfeng JIAO
  • Publication number: 20210379019
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a glucokinase-mediated disorder, disease, or condition in a renally impaired subject with a glucokinase activator (GKA), for example, dorzagliatin. Also provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a diabetes in a renally impaired subject with a GKA. Additionally, provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a chronic kidney disease with a GKA.
    Type: Application
    Filed: June 3, 2021
    Publication date: December 9, 2021
    Inventors: Li CHEN, Shuang REN, Chengfeng JIAO, Yaohui WANG
  • Publication number: 20210330690
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator and a sodium-glucose cotransporter-2 inhibitor.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 28, 2021
    Inventors: Li Chen, Shuang Ren, Jiayi Zhang
  • Publication number: 20210236486
    Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator, optionally in combination with a dipeptidyl peptidase-4 inhibitor.
    Type: Application
    Filed: January 29, 2021
    Publication date: August 5, 2021
    Inventors: Li Chen, Shuang Ren, Jiayi Zhang
  • Publication number: 20150201910
    Abstract: Disclosed herein is a system and method for generating a motion-corrected 2D image of a target. The method comprises acquiring a 3D static image of the target before an interventional procedure. During the procedure, a number of 2D real time images of the target are acquired and displayed. A slice of the 3D static image is acquired and registered with one 2D real time image and then the location of the 3D static image is corrected to be in synchrony with body motion. The motion corrected 2D image of the target is then displayed.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 23, 2015
    Applicant: CENTRE FOR IMAGING TECHNOLOGY COMMERCIALIZATION (CIMTEC)
    Inventors: Shuang-ren ZHAO, Aaron Fenster, Tharindu De Silva, Aaron D. Ward
  • Publication number: 20100207942
    Abstract: One object of the present disclosure is to provide an interpolation method for reconstructing an imaged object with the image edge as sharp as possible and the image itself as smooth as possible. An The EM (Expectation Maximization) image reconstruction is provided that suitable for freehand ultrasound systems.
    Type: Application
    Filed: January 28, 2010
    Publication date: August 19, 2010
    Applicant: EIGEN, INC.
    Inventor: Shuang Ren Zhao